QA: Mylan INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000069499_2012_Mylan_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000069499, Mylan INC

  xvar xval
0 AssetsCurrent 3,568,844,000
1 IntangibleAssetsNetIncludingGoodwill 6,148,682,000
2 PropertyPlantAndEquipmentNet 1,298,034,000
3 remainder_Assets 582,583,000
4 LiabilitiesCurrent 2,563,156,000
5 LiabilitiesNoncurrent 4,845,180,000
6 remainder_Liabilities 685,025,000
7 CostOfGoodsAndServicesSold 3,566,461,000
8 SellingGeneralAndAdministrativeExpense 1,214,631,000
9 ResearchAndDevelopmentExpense 294,728,000
10 remainder_Expenses 500,333,000
11 remainder_Revenues 6,129,825,000
12 remainder_NetIncome -14,869,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,598,143,000
1 Liabilities 8,093,361,000
2 Expenses 5,576,153,000
3 Revenues 6,129,825,000
4 StockholdersEquity 3,504,782,000
5 NetIncome 538,803,000
6 ComprehensiveNetIncome 538,803,000
7 BaseVar 15,706,175,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.831
9 EconomicCapitalRatio 2.17

Edgar->Model Mapping

Feature Distribution

Change over Time